MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mineralys Therapeutics (MLYS) Ownership - Who owns Mineralys Therapeutics?
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone... Show more
Profile
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
847.28M
P/E Ratio
N/A
Total Cash
343.03M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLYS
Capitalization
847M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
343M
Total Cash/Share
5.26
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
342M
P/B Ratio
2.48
Cash Flow
N/A
Earnings
-3.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
26.48
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-201.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-53.69
Shares Held By Institutions
1.27B
Shares Outstanding - Current
65.2M
Total Liabilities
13.4M
Total Volume MTD
N/A
Value
1
Gain YTD
5.605
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLYS showed earnings on May 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com